Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. (Q42369171)
Jump to navigation
Jump to search
scientific article published on 18 September 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. |
scientific article published on 18 September 2017 |
Statements
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial (English)
Keira Annie Markey
1 reference
Ryan Ottridge
1 reference
James L Mitchell
1 reference
Caroline Rick
1 reference
Rebecca Woolley
1 reference
Natalie Ives
1 reference
Peter Nightingale
1 reference
Alexandra J Sinclair
1 reference
18 September 2017